At a glance
ClinicalIndex Comparison RecordN/ACompleted· 92 enrolled
Drug / intervention
Antibiotic +3 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dietary Study of a Complex Oligosaccharide With and Without a Probiotic Following Antibiotic Treatment in Healthy Volunteers
In Brief
An observational study evaluating Antibiotic, HMO Concentrate, and 2 other interventions for Healthy Adults. Completed, enrolled 92 participants across 1 site.
Detailed Summary
Complex oligosaccharides can alter the gut microbiome by aiding in the growth of certain organisms, and possibly, inhibiting others. The synergy with a probiotic may enhance gastrointestinal colonization.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Adults
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartSep 2021
First PostedDec 2021
Primary CompletionMay 2022
Study CompletionJun 2022
TodayJul 2026
First PostedDec 2, 2021
Enrollment StartSep 21, 2021
Primary CompletionMay 23, 2022
Study CompletionJun 9, 2022
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 4.6 years ago
Interventions
Antibioticdietary
Vancomycin (250 mg/dose), Metronidazole (500 mg/dose)
HMO Concentratedietary
Concentrated milk fortifiers from donor human milk
Probioticdietary
B. infantis
Food Supplementdietary
Synthetic powder containing 2'-fucosyllactose (2'-FL) and lactoneotetraose (LNnT)